CME: Offering mifepristone as an abortion option

Article

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.

Recent Videos
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Clinical pearls of pediatric dermatology | Image Credit: profiles.ucsf.edu
Managing skin health in women | Image Credit: profiles.ucsf.edu.
The importance of maternal vaccination | Image Credit: nfid.org.
John Stanley, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.